Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
16.47
-0.08 (-0.48%)
At close: Dec 22, 2025, 4:00 PM EST
16.47
0.00 (0.00%)
After-hours: Dec 22, 2025, 4:10 PM EST
Phreesia Market Cap
Phreesia has a market cap or net worth of $992.93 million as of December 22, 2025. Its market cap has decreased by -18.78% in one year.
Market Cap
992.93M
Enterprise Value
893.37M
1-Year Change
-18.78%
Ranking
Category
Stock Price
$16.47
Market Cap Chart
Since July 18, 2019, Phreesia's market cap has increased from $882.45M to $992.93M, an increase of 12.52%. That is a compound annual growth rate of 1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 997.75M | -31.77% |
| Dec 31, 2024 | 1.46B | 13.55% |
| Dec 29, 2023 | 1.29B | -24.54% |
| Dec 30, 2022 | 1.71B | -20.04% |
| Dec 31, 2021 | 2.13B | -10.92% |
| Dec 31, 2020 | 2.40B | 150.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |